Ala Alenazi

Ala Alenazi is an experienced investment manager with a focus on bio and AI sectors, currently serving at Kinnevik since January 2024. Prior roles include Board Observer at Tailor Bio and Principal at Ascension, where Ala Alenazi was involved in multiple investments in techbio companies. This includes acting in various capacities at companies such as Qureight, Panakeia, and AMLo Biosciences. Education includes a Ph.D. in Molecular Genetics from the University of Cambridge, a Master's degree in Human Molecular Genetics from Imperial College London, and further studies at Harvard Business School Online in finance.